Dianthus Therapeutics (DNTH) Receivables - Other (2018 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Receivables - Other of $50000.0 for Q4 2025, down 75.0% year-over-year from $200000.0 in Q4 2024, and down 50.0% quarter-over-quarter from $100000.0 in Q3 2025.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Receivables - Other (2018 - 2025) Analysis & Trends
Dianthus Therapeutics' Receivables - Other history runs 6 years deep, the most recent figure standing at $50000.0 for Q4 2025.
- In Q4 2025, Receivables - Other fell 75.0% year-over-year to $50000.0; the TTM figure through Dec 2025 stood at $50000.0 (down 75.0% YoY), while the FY2025 annual figure was $50000.0, down 93.8% from the prior year.
- Receivables - Other for Q4 2025 stood at $50000.0, down from $100000.0 in the prior quarter.
- The five-year high for Receivables - Other was $1.3 million in Q3 2024, with the low at $50000.0 in Q4 2025.
- The 4-year median for Receivables - Other is $300000.0 (2025), against an average of $442636.4.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other surged 150.48% in 2024, then slumped 92.31% in 2025.
- Dianthus Therapeutics' Receivables - Other stood at $900000.0 in 2022, then tumbled by 77.78% to $200000.0 in 2023, then changed by 0.0% to $200000.0 in 2024, then slumped by 75.0% to $50000.0 in 2025.
- Business Quant data shows DNTH's Receivables - Other at $50000.0 in Q4 2025, $100000.0 in Q3 2025, and $100000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Dianthus Therapeutics | 4.09 Bn | 3.69 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 50,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 807,000.00 |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 519,000.00 |
| Dec 31, 2022 | 900,000.00 |
| Sep 30, 2019 | 100,000.00 |
| Dec 31, 2018 | 100,000.00 |